These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31378329)

  • 41. Case studies with the experts: management decisions in atrial fibrillation.
    Prystowsky EN; Jaïs P; Kowey P; Nattel S; Ruskin JN
    J Cardiovasc Electrophysiol; 2008 Feb; 19 Suppl 1():S1-12; quiz S13-5. PubMed ID: 18226097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drugs for conversion of atrial fibrillation.
    Dell'Orfano JT; Luck JC; Wolbrette DL; Patel H; Naccarelli GV
    Am Fam Physician; 1998 Aug; 58(2):471-80. PubMed ID: 9713400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.
    Xu X; Alida CT; Yu B
    Cardiovasc Ther; 2015 Aug; 33(4):242-6. PubMed ID: 26031448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atrial fibrillation and heart failure: beyond the heart rate.
    Garg A; Akoum N
    Curr Opin Cardiol; 2013 May; 28(3):332-6. PubMed ID: 23549231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.
    Opolski G; Torbicki A; Kosior DA; Szulc M; Wozakowska-Kaplon B; Kolodziej P; Achremczyk P;
    Chest; 2004 Aug; 126(2):476-86. PubMed ID: 15302734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of rhythm and rate control in patients with atrial fibrillation.
    Prystowsky EN
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S7-10. PubMed ID: 16939436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of atrial fibrillation in patients with heart failure: from drug therapy to ablation.
    Wongcharoen W; Chen SA
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):311-22. PubMed ID: 19296769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of atrial fibrillation in the acute setting.
    Chenoweth J; Diercks DB
    Curr Opin Crit Care; 2012 Aug; 18(4):333-40. PubMed ID: 22622515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Catheter ablation for atrial fibrillation: who, why and does it work?
    Eyre-Brook SN; Rajappan K
    Postgrad Med J; 2012 Oct; 88(1044):604-11. PubMed ID: 22761325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.
    Nattel S; Khairy P; Roy D; Thibault B; Guerra P; Talajic M; Dubuc M
    Drugs; 2002; 62(16):2377-97. PubMed ID: 12396229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation.
    Willems S; Meyer C; de Bono J; Brandes A; Eckardt L; Elvan A; van Gelder I; Goette A; Gulizia M; Haegeli L; Heidbuchel H; Haeusler KG; Kautzner J; Mont L; Ng GA; Szumowski L; Themistoclakis S; Wegscheider K; Kirchhof P
    Eur Heart J; 2019 Dec; 40(46):3793-3799c. PubMed ID: 31755940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular Disease Update: Atrial Fibrillation.
    McDivitt JD; Barstow C
    FP Essent; 2017 Mar; 454():11-17. PubMed ID: 28266823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atrial fibrillation: antiarrhythmic therapy versus rate control with antithrombotic therapy.
    Sager PT
    Am J Cardiol; 1997 Oct; 80(8A):74G-81G. PubMed ID: 9354414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation.
    Trulock KM; Narayan SM; Piccini JP
    J Am Coll Cardiol; 2014 Aug; 64(7):710-21. PubMed ID: 25125304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tailored treatment strategies: a new approach for modern management of atrial fibrillation.
    Van Gelder IC; Hobbelt AH; Marcos EG; Schotten U; Cappato R; Lewalter T; Schwieler J; Rienstra M; Boriani G
    J Intern Med; 2016 May; 279(5):457-66. PubMed ID: 26991684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of recent-onset sustained atrial fibrillation: pharmacologic and nonpharmacologic strategies.
    Lau DH; Kalman J; Sanders P
    Clin Ther; 2014 Sep; 36(9):1151-9. PubMed ID: 25234548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Catheter Ablation as First-Line Therapy for Atrial Fibrillation: Ready for Prime-Time?
    Carrizo AG; Morillo CA
    Curr Cardiol Rep; 2016 Jul; 18(8):71. PubMed ID: 27300744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of atrial fibrillation in heart failure in the elderly.
    Abi Nasr I; Mansencal N; Dubourg O
    Int J Cardiol; 2008 Apr; 125(2):178-82. PubMed ID: 18029038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The patient with atrial fibrillation.
    Indik JH; Alpert JS
    Am J Med; 2009 May; 122(5):415-8. PubMed ID: 19375546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiarrhythmic drug therapy for atrial fibrillation.
    Sardar MR; Saeed W; Kowey PR
    Cardiol Clin; 2014 Nov; 32(4):533-49. PubMed ID: 25443235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.